Healthcare -
Biotechnology - NASDAQ - US
$ 2.68
0 %
$ 77.7 M
Market Cap
-0.045042016806722686
P/E
AVTE - OPERATING INCOME
Operating Income AVTE - Aerovate Therapeutics, Inc.
-74.6 M
LAST VALUE
-18.37%
2 YEAR CAGR
-86.22%
5 YEAR CAGR
0.00%
10 YEAR CAGR